Abbonarsi

Comparison of intravascular access methods applied by nurses wearing personal protective equipment in simulated COVID-19 resuscitation: A randomized crossover simulation trial - 29/10/21

Doi : 10.1016/j.ajem.2021.05.080 
Anna Drozd, MD a, Jacek Smereka, PhD, MD b, Michal Pruc, MS a, Marek Malysz, MSc, EMT-P a, Aleksandra Gasecka, PhD, MD c, d, Leyla Ozturk Sonmez, PhD, MD e, Maciej Cyran, MD f, Lars Konge, PhD g, Lukasz Szarpak, PhD, MBA a, h,
a Polish Society of Disaster Medicine, Warsaw, Poland 
b Department of Emergency Medical Service, Wroclaw Medical University, Wroclaw, Poland 
c Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands 
d 1st Chair and Department of Cardiology, Medical University of Warsaw, Poland 
e Department of Emergency Medicine, Beyhekim Training and Research Hospital, Konya, Turkey 
f Maria Sklodowska-Curie Medical Academy in Warsaw, Poland 
g Copenhagen Academy for Medical Education and Simulation, Centre for HR and Education, University of Copenhagen, Copenhagen, Denmark 
h Maria Sklodowska-Curie Bialystok Oncology Center, Bialystok, Poland 

Corresponding author at: Maria Sklodowska-Curie Bialystok Oncology Center, Bialystok, Poland.Maria Sklodowska-Curie Bialystok Oncology CenterBialystokPoland

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Abstract

Background

Prehospital emergency care of children is challenging. In the era of the COVID-19 pandemic, when medical personnel should use personal protective equipment against aerosol-generating procedures, the efficiency of medical procedures may decrease. The study objective was to evaluate the effectiveness of different intravascular access methods applied by nurses wearing biosafety Level-2 suits in simulated paediatric COVID-19 resuscitation.

Methods

A prospective, randomized, crossover, single-blinded simulation trial was performed. Nursing staff attending Advanced Cardiovascular Life Support courses accredited by the American Heart Association participated in the study. A total of 65 nurses were recruited and randomly assigned to different study groups. They received standard training on intravascular access methods employing distinct devices. The participants wore biosafety Level-2 suits and performed vascular access with the following intraosseous devices: NIO-P, EZ-IO, and Jamshidi needle; intravenous (IV) access was used as a reference method. Both the order of participants and the access methods were random. Each participant performed intravascular access with each of the four methods tested. The effectiveness of the first attempt to obtain intravascular access and the following time parameters were analysed: the time between grasping the intravascular device out of the original packing until infusion line connection. The ease of the procedure was measured with a visual analogue scale (1 – easy; 10 – difficult).

Results

The first attempt success rate of intravascular access by using NIO-P and EZ-IO equalled 100% and was statistically significantly higher than that with the Jamshidi needle (80.0%; p = 0.02) and with the IV method (69.2%; p = 0.005). The time required to connect the infusion line varied and amounted to 33 ± 4 s for NIO-P compared to 37 ± 6.7 s for EZ-IO (p < 0.001), 43 ± 7 s for Jamshidi (p < 0.001), and 98.5 ± 10 s for IV access (p < 0.001). The procedure was easiest in the case of NIO-P and EZ-IO (2 ± 1 points; p = 1.0) compared with Jamshidi (5 ± 3 points; p < 0.001) and IV access (7 ± 2 points; p < 0.001).

Conclusion

The study provides evidence that nurses wearing biosafety Level-2 suits were able to obtain intraosseous access faster and more effectively as compared with IV access during simulated COVID-19 paediatric resuscitation. The most effective method of intravascular access was the NIO-P intraosseous device. Further clinical trials are necessary to confirm the results.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Intraosseous access, Intravascular access, Child, Cardiopulmonary resuscitation, Personal protective equipment, COVID-19, SARS-CoV-2, Coronavirus, Infection, Medical simulation

Abbreviations : AGP, CI, IO, IRB, IV, MD, OR, PPE


Mappa


© 2021  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 49

P. 189-194 - novembre 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Association between patients' body mass index and emergency department wait times: A multicenter observational cohort investigation by the reducing disparities increasing equity in emergency medicine (REDEEM) study group
  • Isabella M. Lichen, Venkatesh R. Bellamkonda, Ronna L. Campbell, Sean M. Phelan, Joel R. Anderson, Aidan F. Mullan, Kit Knier, Annie T. Sadosty
| Articolo seguente Articolo seguente
  • Prehospital, post-ROSC blood pressure and associated neurologic outcome
  • Jeremy Lacocque, Lee Siegel, Karl A. Sporer

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.